Judy Perkins

Ms. Perkins is a cancer survivor, patient advocate, and community educator. While she had over 20 years engineering experience, her breast cancer resume began in 2013 with a Metastatic Breast Cancer (MBC) diagnosis. She quickly became interested in learning about all things breast cancer. Since her MBC diagnosis, she has been a frequent contributor to the Inspire discussion group for Advanced Breast Cancer. She attended Metastatic Breast Cancer Network (MBCN) conferences (2013 and 2014) and National Breast Cancer Coalition (NBCC) Summits (2014, 2016 – 2018) including going to Capitol Hill to advocate for funding for breast cancer research. She has served on four DoD Breast Cancer Research Program (BCRP) panels and attended Project LEAD in 2015. In December 2016, she attended San Antonio Breast Cancer Symposium (SABCS). In 2017 she became a member of the Florida Breast Cancer Foundation’s Scientific Committee.

Ms. Perkins is an informed MBC advocate and, as a patient, participated in two clinical trials including Lucitanib (an FGFR1 inhibitor) and an NIH immunotherapy trial using tumor infiltrating lymphocytes. In December 2015, she became the first breast cancer patient in the United States to receive Dr. Steve Rosenberg’s selective Tumor Infiltrating Lymphocytes (TILs) treatment. She now appears to be cancer free and is enjoying her miraculous cure. She continues to participate in breast cancer research and advocacy.